IQ Candriam US Mid Cap Equity ETF
IQSM
3 hedge funds and large institutions have $86.1M invested in IQ Candriam US Mid Cap Equity ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
1,574% more capital invested
Capital invested by funds: $5.15M → $86.1M (+$81M)
200% more funds holding
Funds holding: 1 → 3 (+2)
4.67% more ownership
Funds ownership: 95% → 99.67% (+4.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NYLIM
New York Life Investment Management
New York
|
+$74M |
| 2 |
Jane Street
New York
|
+$2.18M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$380K |
Top Sellers
IQSM Hedge Fund Activity: Q2 2023 in Review
3 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in IQ Candriam US Mid Cap Equity ETF (IQSM) for Q2 2023, worth a combined $86.1M — up 1,574% from $5.15M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IQSM positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was New York Life Investment Management, adding an estimated $74M.
- 3 institutional investors held IQ Candriam US Mid Cap Equity ETF (IQSM) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $86.1M of IQ Candriam US Mid Cap Equity ETF stock for Q2 2023, up 1,574% quarter-over-quarter.
- 2 funds opened new IQ Candriam US Mid Cap Equity ETF positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest IQ Candriam US Mid Cap Equity ETF buyer in Q2 2023 was New York Life Investment Management, an estimated $74M added.
Based on aggregated 13F filings for Q2 2023.